rxstat › Shortages › Tolterodine

Tolterodine shortage status

Widespread shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Tolterodine is in a widespread shortage in Canada. 8 of 16 reported products are affected. The latest manufacturer estimate for full recovery is Sep 8, 2026.
Products affected
8 / 16
In shortage since
Oct 4, 2023
Est. full return
Sep 8, 2026
Reports on file
81
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
DETROL
1MG · TABLET · BGP PHARMA ULC
DIN 02239064 · since Dec 30, 2025, no end estimate · Demand increase for the drug.
Active shortage
JAMP TOLTERODINE
2MG · TABLET · JAMP PHARMA CORPORATION
DIN 02496844 · since Oct 31, 2025, est. end Aug 14, 2026 · Demand increase for the drug.
Active shortage
TEVA-TOLTERODINE LA
4MG · CAPSULE (EXTENDED RELEASE) · TEVA CANADA LIMITED
DIN 02412209 · since Dec 11, 2024, est. end Aug 31, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-TOLTERODINE LA
2MG · CAPSULE (EXTENDED RELEASE) · TEVA CANADA LIMITED
DIN 02412195 · since Nov 27, 2024, est. end Jul 20, 2026 · Disruption of the manufacture of the drug.
Active shortage
DETROL LA
4MG · CAPSULE (EXTENDED RELEASE) · BGP PHARMA ULC
DIN 02244613 · since Jun 5, 2026, est. end Sep 8, 2026 · Disruption of the manufacture of the drug.
Active shortage
DETROL LA
2MG · CAPSULE (EXTENDED RELEASE) · BGP PHARMA ULC
DIN 02244612 · since Jun 1, 2026, est. end Sep 8, 2026 · Demand increase for the drug.
Active shortage
TEVA-TOLTERODINE
2MG · TABLET · TEVA CANADA LIMITED
DIN 02299607 · since Oct 4, 2023, est. end Jun 30, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-TOLTERODINE
1MG · TABLET · TEVA CANADA LIMITED
DIN 02299593 · since Oct 4, 2023, est. end Jun 30, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-TOLTERODINE LA
2MG · CAPSULE (EXTENDED RELEASE) · TEVA CANADA LIMITED
DIN 02412195 · since Dec 18, 2024, no end estimate · Disruption of the manufacture of the drug.
Resolved
DETROL LA
2MG · CAPSULE (EXTENDED RELEASE) · BGP PHARMA ULC
DIN 02244612 · ended May 19, 2026 · Disruption of the manufacture of the drug.
Resolved
DETROL LA
4MG · CAPSULE (EXTENDED RELEASE) · BGP PHARMA ULC
DIN 02244613 · ended May 19, 2026 · Disruption of the manufacture of the drug.
Resolved
SANDOZ TOLTERODINE LA
2MG · CAPSULE (EXTENDED RELEASE) · SANDOZ CANADA INCORPORATED
DIN 02413140 · ended Apr 13, 2026 · Disruption of the manufacture of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Tolterodine is currently affected by 8 active shortage reports filed with Health Canada by BGP PHARMA ULC, JAMP PHARMA CORPORATION, TEVA CANADA LIMITED.

The reported causes are: demand increase for the drug; disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Tolterodine is classified under “OTHER UROLOGICALS, INCL ANTISPASMODICS” (ATC G04BD).

Recent changes

Common questions

When will Tolterodine be back in stock in Canada?

The latest manufacturer estimate is Sep 8, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Tolterodine in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (other urologicals, incl antispasmodics)

Widespread shortageAlprostadil3 of 5 reported products affectedWidespread shortageFlavoxate2 of 2 reported products affectedWidespread shortageMirabegron2 of 2 reported products affected · est. return Jul 3, 2026Partial shortageDarifenacin1 of 6 reported products affected · est. return Jul 10, 2026Partial shortageFesoterodine1 of 4 reported products affected · est. return Jan 29, 2027Partial shortageOxybutynin Chloride2 of 11 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.